Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of EC-18 in COVID-19 Infection Progressing to Pneumonia
KCT0005344Phase 2Completed
- Sponsor
- Enzychem Lifesciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosedipimod in coronavirus disease 2019 (COVID-19), sponsored by Enzychem Lifesciences. Started Jun 2020; status: completed.
02
Drugs
mosedipimod
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on KCT0005344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005344.